Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DarioHealth Corp. stock logo
DRIO
DarioHealth
$1.46
-2.7%
$1.63
$0.68
$4.58
$43.33M1.66134,557 shs42,921 shs
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
$1.55
+5.4%
$8.06
$2.57
$10.42
$6.78M0.645,308 shs102 shs
Neovasc Inc. stock logo
NVCN
Neovasc
$30.03
$29.69
$4.59
$30.07
$82.28M1.756,993 shs1 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$0.04
-5.4%
$0.09
$0.02
$1.82
$830K1.4622.12 million shs15.44 million shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DarioHealth Corp. stock logo
DRIO
DarioHealth
+3.45%+23.97%+0.67%-27.88%-54.13%
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
+5.76%+5.58%-4.20%+47.81%+55.20%
Neovasc Inc. stock logo
NVCN
Neovasc
0.00%0.00%0.00%0.00%0.00%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
+8.10%+3.75%-22.60%-86.60%-97.61%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DarioHealth Corp. stock logo
DRIO
DarioHealth
1.5493 of 5 stars
3.51.00.00.01.80.81.3
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
N/AN/AN/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DarioHealth Corp. stock logo
DRIO
DarioHealth
3.00
Buy$5.37267.58% Upside
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
N/AN/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
N/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.00
HoldN/AN/A

Current Analyst Ratings

Latest NVCN, IDXG, DRIO, and SINT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
DarioHealth Corp. stock logo
DRIO
DarioHealth
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00
2/5/2024
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DarioHealth Corp. stock logo
DRIO
DarioHealth
$20.35M2.13N/AN/A$2.14 per share0.68
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
$40.21M0.17$0.67 per share2.32($14.16) per share-0.11
Neovasc Inc. stock logo
NVCN
Neovasc
$3.81M21.60N/AN/A$5.77 per share5.20
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.63M0.32N/AN/A$1.65 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$59.43M-$1.03N/AN/AN/A-165.96%-48.84%-31.56%5/9/2024 (Estimated)
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
$800K-$0.39N/AN/A1.99%-1.79%7.53%5/10/2024 (Estimated)
Neovasc Inc. stock logo
NVCN
Neovasc
-$41.20M-$15.08N/AN/A-1,082.92%-127.25%-80.31%N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$8.26M-$3.42N/AN/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)

Latest NVCN, IDXG, DRIO, and SINT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$0.54-$0.41+$0.13-$0.41$3.57 million$3.62 million
3/27/2024Q4 2023
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A-$0.09-$0.09-$0.09N/A$0.90 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DarioHealth Corp. stock logo
DRIO
DarioHealth
N/AN/AN/AN/AN/A
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
N/AN/AN/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.42
3.79
3.38
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
N/A
0.59
0.59
Neovasc Inc. stock logo
NVCN
Neovasc
0.80
2.96
2.85
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
1.90
1.60

Ownership

Institutional Ownership

CompanyInstitutional Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
33.39%
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
5.73%
Neovasc Inc. stock logo
NVCN
Neovasc
1.64%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%

Insider Ownership

CompanyInsider Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
10.10%
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
6.50%
Neovasc Inc. stock logo
NVCN
Neovasc
N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
DarioHealth Corp. stock logo
DRIO
DarioHealth
27629.68 million26.47 millionOptionable
Interpace Biosciences, Inc. stock logo
IDXG
Interpace Biosciences
1524.37 million4.08 millionNot Optionable
Neovasc Inc. stock logo
NVCN
Neovasc
492.74 millionN/ANot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
4122.68 million22.45 millionNot Optionable

NVCN, IDXG, DRIO, and SINT Headlines

SourceHeadline
Why SINTX Technologies Stock Is Getting HammeredWhy SINTX Technologies Stock Is Getting Hammered
msn.com - April 3 at 2:48 PM
SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
globenewswire.com - April 3 at 9:00 AM
Why SINTX Technologies Stock Hit A New All-Time Low TodayWhy SINTX Technologies Stock Hit A New All-Time Low Today
msn.com - April 1 at 3:51 PM
DDC Appoints Vice President to Drive Operational ExcellenceDDC Appoints Vice President to Drive Operational Excellence
itnewsonline.com - March 30 at 6:23 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 29 at 4:00 PM
SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 28 at 7:02 AM
Sintx Technologies Prices Public Offering Of $1.3 Mln Of SharesSintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
markets.businessinsider.com - March 25 at 1:22 PM
Why SINTX Technologies Stock Is Down 50%Why SINTX Technologies Stock Is Down 50%
msn.com - March 25 at 1:22 PM
Why Is Sintx Technologies (SINT) Stock Down 31% Today?Why Is Sintx Technologies (SINT) Stock Down 31% Today?
investorplace.com - March 25 at 9:05 AM
SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
globenewswire.com - March 25 at 9:00 AM
US Stocks Edge Lower; FedEx Posts Upbeat EarningsUS Stocks Edge Lower; FedEx Posts Upbeat Earnings
msn.com - March 23 at 3:15 AM
Why SINTX Technologies Is Trading Higher TodayWhy SINTX Technologies Is Trading Higher Today
aol.com - March 22 at 10:14 PM
Gold Moves Lower; Lululemon Shares PlummetGold Moves Lower; Lululemon Shares Plummet
msn.com - March 22 at 5:14 PM
Dow Dips 200 Points; Nike Shares Fall After Q3 ResultsDow Dips 200 Points; Nike Shares Fall After Q3 Results
markets.businessinsider.com - March 22 at 5:14 PM
SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%
markets.businessinsider.com - March 22 at 5:14 PM
Why SINTX Technologies Stock Is NosedivingWhy SINTX Technologies Stock Is Nosediving
msn.com - March 22 at 5:14 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 22 at 8:30 AM
Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20
msn.com - February 24 at 2:14 PM
Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
benzinga.com - February 23 at 7:50 AM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
finance.yahoo.com - February 21 at 3:58 PM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
globenewswire.com - February 21 at 9:00 AM
SINTX Technologies: Other EventsSINTX Technologies: Other Events
cbonds.com - February 16 at 10:37 AM
SINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturing
tctmagazine.com - February 7 at 10:57 AM
Sintx Technologies just downgraded at Maxim, heres whySintx Technologies just downgraded at Maxim, here's why
realmoney.thestreet.com - February 5 at 5:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

DarioHealth logo

DarioHealth

NASDAQ:DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Interpace Biosciences logo

Interpace Biosciences

NASDAQ:IDXG
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Neovasc logo

Neovasc

NASDAQ:NVCN
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.
Sintx Technologies logo

Sintx Technologies

NASDAQ:SINT
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.